Charlie Health, the leading provider of virtual high-acuity behavioral healthcare, announced the launch of its dedicated virtual treatment program for individuals with primary substance use disorders (SUD). Building on years of experience supporting clients with co-occurring substance use and mental health conditions, the program formalizes and expands Charlie Health’s proven virtual intensive treatment model to serve teens and adults whose primary need is SUD care—delivering personalized support, specialized clinical expertise, and fully integrated, measurement-based treatment.
The virtual SUD program offers multiple weekly sessions, including groups, individual therapy, family therapy, and medication-assisted treatment (MAT). Clients are placed in curated peer cohorts and matched with a dedicated care team, ensuring clinically aligned support throughout treatment. MAT—including buprenorphine or naltrexone—is delivered as part of a coordinated care plan to ensure treatment aligns with progress.
Health Technology Insights:Biocon Biologics Gets Positive CHMP Opinion for Denosumab
All services are delivered virtually, allowing clients to stay engaged with school, work, and family while receiving consistent support.
The launch comes in response to a widespread need: more than 46 million Americans struggle with substance use disorders, yet only six percent receive treatment each year, according to the National Survey on Drug Use and Health. Charlie Health’s substance use disorder offering addresses this gap by enabling access to evidence-based substance use treatment paired with comprehensive mental health support, ensuring that clients receive coordinated care in one connected experience.
“We work directly in communities every day and see just how real the need is for accessible and effective substance use treatment,” said Carter Barnhart, CEO and Co-Founder of Charlie Health. “This program reflects what we’ve believed—and proven—since day one at Charlie Health: that connection paired with evidence-based care saves lives. We’re proud to offer a new path forward for those navigating recovery—one that’s integrated, supportive, and built for lasting recovery.”
Health Technology Insights: Abbott Unveils New AVEIR Data, Launches Conduction Pacing Trial
Charlie Health consistently delivers strong outcomes for clients with substance use concerns, including those with co-occurring mental health conditions. Among this group, 94% of clients who completed treatment did not require readmission to a higher level of care within three months of discharge. Clients completing care also reported an 84% reduction in opioid use and an 80% reduction in alcohol use. Mental health symptoms improved significantly for this population as well, with over 70% reductions in both self-harm and suicidal ideation, and reductions of 47% and 46% in symptoms of depression and anxiety, respectively.
Health Technology Insights: Abbott’s Volt PFA System Shows Long-Term Benefits for AFib
Strengthening support between sessions
To further enhance accountability and clinical outcomes, Charlie Health has partnered with You Are Accountable, a peer-led recovery support program that offers virtual coaching and at-home drug and alcohol testing. This partnership provides clients with an added layer of structure between therapy sessions and helps reinforce real-world recovery skills.
“At You Are Accountable, we believe recovery is sustained through connection, accountability, and trusted support,” said Matthew Serel, CEO and Co-Founder of You Are Accountable. “Together with Charlie Health, we’re reinforcing the bridge between treatment and real-world recovery, ensuring individuals have the resources and support they need to stay well and build a sustained, dignified, and fulfilling life in recovery.”
With this launch, Charlie Health is expanding access to high-quality virtual substance use treatment—bringing together clinical precision and meaningful connection to support lasting recovery.
Health Technology Insights: Ferrer Partners with Prilenia for Pridopidine Co-Development
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
